マイクロ流体市場:製品別(デバイス、コンポーネント(チップ、センサー、マイクロニードル、ポンプ、バルブ)、用途別(IVD(POC、臨床、獣医)、研究(プロテオミック、ゲノム、セルベース、キャピラリー)、製造)、エンドユーザー別(製薬、病院) - 2028年までの世界予測Microfluidics Market by Product (Device, Component (Chip, Sensor, Microneedle, Pump, Valve), Application (IVD (POC, Clinical, Vet), Research (Proteomic, Genomic, Cell-based, Capillary), Manufacturing), End User (Pharma, Hospital) - Global Forecast to 2028 マイクロフルイディクス市場は、2023年に223億米ドルと推定され、予測期間中の年平均成長率は13.0%で、2028年には411億米ドルに達すると予測されている。マイクロ流体技術は、迅速な分析、試薬使用の削減、信頼性... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーマイクロフルイディクス市場は、2023年に223億米ドルと推定され、予測期間中の年平均成長率は13.0%で、2028年には411億米ドルに達すると予測されている。マイクロ流体技術は、迅速な分析、試薬使用の削減、信頼性の高い検査結果を提供することで、医薬品開発プロセス全体のコストを最小限に抑えます。これらすべての要因に加え、グルコースモニターや妊娠検査キットのようなポイントオブケア診断ツールの使用と受け入れが拡大した結果、マイクロ流体技術に対する需要が高まっている。"マイクロ流体ベースのデバイスセグメントは、予測期間中、マイクロ流体市場で製品のタイプ別に最も高い成長を目撃すると予測されている。" マイクロ流体市場は、製品によってマイクロ流体ベースのデバイスとマイクロ流体コンポーネントに大別される。製品別マイクロ流体市場は、2022年にはマイクロ流体ベースのデバイスセグメントが主流となる。このセグメントの成長率が最も高いのは、製薬・ライフサイエンス研究において技術的に洗練されたマイクロ流体ベースデバイスの利用が拡大していること、実験装置の小型化に対する要求が高まっていること、マイクロ流体ベースのPoCテストに対する消費者需要が増加していること、創薬へのマイクロ流体技術の応用が拡大していることなどが主な要因である。 "製品タイプ別では、マイクロ流体チップ分野が予測期間中に最も高い割合を占める" 流量・圧力センサー、流量・圧力コントローラー、マイクロポンプ、マイクロ流体バルブ、マイクロニードル、その他のマイクロ流体コンポーネントがタイプ別市場を構成するマイクロ流体コンポーネントの種類である。2022年のマイクロ流体コンポーネント市場は、マイクロ流体チップのカテゴリーが支配的であった。このマイクロ流体市場セグメントの成長は、PoC検査需要の高まり、個別化医療への嗜好の高まり、創薬・ライフサイエンス研究活動の増加、高速診断へのニーズの高まり、政府資金の増加などの要因によるものである。 「予測期間中、アジア太平洋市場が最も高い成長を遂げる 予測期間中、APACは最も速い速度で成長すると予測されている。この地域におけるマイクロ流体市場の成長を促進する主な要因は、高齢者数の増加、一人当たり所得の上昇、主要企業による医療産業への投資の増加、先端技術への需要の増加、アジア太平洋地域の様々な国々における農村部への民間病院の拡大などである。 本レポートで参照したマイクロ流体市場の主要参入企業(供給側)の内訳は以下の通りである: a - 企業タイプ別:ティア1:42%、ティア2:35%、ティア3:23 - 役職別Cレベル幹部:28%、取締役:35%、その他:2335%、その他37% - 地域別北米:33%、ヨーロッパ:24%、アジア太平洋地域:18%、ラテンアメリカ:10%、中東:10%、アフリカ:5 マイクロ流体市場に参入している主な企業は、Parker Hannifin Corporation(米国)、SMC Corporation(日本)、Bio-Rad Laboratories, Inc.(米国)、Thermo Fisher Scientific Inc.(米国)、PerkinElmer, Inc.(米国)、Agilent Technologies, Inc.(米国)、Fluigent SA(フランス)、Aignep S.P.A. (イタリア)、Camozzi Automation Inc.(イタリア)、Camozzi Automation SPA Societá Unipersonale(イタリア)、Dolomite microfluidics(英国)、Elveflow(フランス)、Becton, Dickinson and Company(米国)、Illumina Inc.(米国)、F. Hoffmann-La Roche Ltd、IDEX Corporation(米国)、Danaher Corporation(米国)、Cellix Limited(アイルランド)、Fortive Corporation(米国)、(スイス)、Fluidigm Corporation(米国)、Abbott Laboratories(米国)。 調査対象範囲 この調査レポートは、さまざまなセグメントにわたるマイクロ流体市場を対象としています。製品別、用途別、エンドユーザー別、地域別など、さまざまなセグメントにわたる市場規模および市場の成長可能性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品および事業内容、最近の動向、主要市場戦略に関する主要な見解も掲載しています。 レポート購入の理由 本レポートは、マイクロ流体市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供することで、同市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より良い事業の位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。 本レポートは、以下のポイントに関する洞察を提供します: 主な促進要因(ポイントオブケア検査需要の高まり、技術進歩の高まり、データの精度と正確さへの注目の高まり、高い経済性、マイクロ流体チップの小型化による迅速な検査と携帯性の向上)、阻害要因(複雑で時間のかかる規制当局の承認プロセス、既存のワークフローへのマイクロ流体の組み込み)の分析、マイクロ流体市場の成長に影響を与える機会(マイクロ流体ベースの3D細胞培養システムの出現、主要成長市場であるアジア、マイクロ流体を用いた薬物送達技術の応用拡大、ライフサイエンスおよび製薬産業におけるマイクロ流体の応用拡大)および課題(マイクロ流体デバイスの標準化/商業化 - 市場への浸透:世界のマイクロ流体市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報を掲載しています。製品タイプ別、用途別、地域別に市場を分析しています。 - 製品の強化/革新:世界のマイクロ流体市場における今後の動向や製品発表に関する詳細な洞察。 - 市場開発:製品タイプ別、用途別、地域別の有利な新興市場に関する包括的情報。 - 市場の多様化:世界のマイクロ流体市場における新製品とサービス、成長地域、最近の開発、投資に関する詳細な情報を提供します。 - 競争力の評価:世界のマイクロ流体市場における主要企業の市場シェア、成長戦略、製品・サービス、能力を詳細に評価します。 目次1 INTRODUCTION 411.1 STUDY OBJECTIVES 41 1.2 MARKET DEFINITION 42 1.2.1 PRODUCT DEFINITIONS 42 1.2.2 INCLUSIONS & EXCLUSIONS 43 1.3 MARKET SCOPE 44 1.3.1 MARKETS COVERED 44 1.3.2 YEARS CONSIDERED 45 1.4 CURRENCY 45 1.5 SCOPE-RELATED LIMITATIONS 46 1.6 STAKEHOLDERS 46 1.7 SUMMARY OF CHANGES 46 1.7.1 ADDITION OF RECESSION IMPACT 47 2 RESEARCH METHODOLOGY 48 2.1 RESEARCH DATA 48 FIGURE 1 RESEARCH DESIGN 48 2.1.1 SECONDARY DATA 49 2.1.1.1 Key data from secondary sources 50 2.1.2 PRIMARY DATA 50 FIGURE 2 PRIMARY SOURCES 51 2.1.2.1 Key data from primary sources 52 2.1.2.2 Key industry insights 53 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 53 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 54 2.2 MARKET SIZE ESTIMATION 54 FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 55 FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: DANAHER CORPORATION 55 FIGURE 7 REVENUE ANALYSIS OF TOP FOUR COMPANIES: MICROFLUIDICS-BASED DEVICES MARKET (2022) 56 FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MICROFLUIDICS MARKET (2023–2028) 58 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 59 FIGURE 10 TOP-DOWN APPROACH 59 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 61 FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 61 2.4 MARKET SHARE ANALYSIS 62 2.5 STUDY ASSUMPTIONS 62 2.6 LIMITATIONS 63 2.7 RISK ASSESSMENT 63 TABLE 1 RISK ASSESSMENT: MICROFLUIDICS MARKET 63 2.8 RECESSION IMPACT ANALYSIS 63 3 EXECUTIVE SUMMARY 64 FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 64 FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 65 FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 65 FIGURE 15 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023 VS. 2028 (USD MILLION) 66 FIGURE 16 MICROFLUIDICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 66 FIGURE 17 GEOGRAPHIC SNAPSHOT: MICROFLUIDICS MARKET 67 4 PREMIUM INSIGHTS 68 4.1 MICROFLUIDICS MARKET OVERVIEW 68 FIGURE 18 RISING DEMAND FOR POCT TO DRIVE GLOBAL MICROFLUIDICS MARKET 68 4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION & COUNTRY 69 FIGURE 19 IVD HELD LARGEST SHARE OF APAC MICROFLUIDICS MARKET IN 2022 69 4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70 FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 70 4.4 REGIONAL MIX: MICROFLUIDICS MARKET (2021–2028) 71 FIGURE 21 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET THROUGHOUT FORECAST PERIOD 71 4.5 MICROFLUIDICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 71 FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES TILL 2028 71 5 MARKET OVERVIEW 72 5.1 MARKET DYNAMICS 72 FIGURE 23 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 72 5.1.1 MARKET DRIVERS 73 5.1.1.1 Rising demand for point-of-care testing 73 FIGURE 24 GLOBAL CANCER INCIDENCE, 2020–2040 73 5.1.1.2 Rising technological advancements 74 TABLE 2 PRODUCT LAUNCHES BY MAJOR PLAYERS IN LAST THREE YEARS 74 5.1.1.3 Increasing focus on data precision and accuracy 74 5.1.1.4 Highly economical solution 75 5.1.1.5 Rapid testing and improved portability through microfluidic chip miniaturization 75 5.1.2 MARKET RESTRAINTS 76 5.1.2.1 Complex and time-consuming regulatory approval process 76 5.1.2.2 Incorporation of microfluidics into existing workflows 76 5.1.3 MARKET OPPORTUNITIES 77 5.1.3.1 Emergence of microfluidic-based 3D cell culture systems 77 5.1.3.2 Growth opportunities in Asia 77 5.1.3.3 Expanding applications of drug delivery technologies using microfluidics 78 5.1.3.4 Growing applications of microfluidics in life science & pharmaceutical industries 78 5.1.4 MARKET CHALLENGES 78 5.1.4.1 Standardization/commercialization of microfluidic devices 78 5.2 INDUSTRY TRENDS 79 5.2.1 SHIFTING TREND TOWARD E-HEALTH DIAGNOSTICS WITH INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES 79 5.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS 79 5.2.3 SHIFTING TREND TOWARDS ADOPTION OF POLYMERS 80 5.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC STARTUPS 80 TABLE 3 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET 80 5.3 VALUE CHAIN ANALYSIS 82 FIGURE 25 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS 83 5.3.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS 83 5.4 SUPPLY CHAIN ANALYSIS 84 FIGURE 26 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS 85 5.5 ECOSYSTEM MARKET MAP 85 FIGURE 27 MICROFLUIDICS MARKET: ECOSYSTEM MARKET MAP 86 5.6 PORTER’S FIVE FORCES ANALYSIS 86 5.6.1 THREAT OF NEW ENTRANTS 87 5.6.2 THREAT OF SUBSTITUTES 87 5.6.3 BARGAINING POWER OF SUPPLIERS 87 5.6.4 BARGAINING POWER OF BUYERS 88 5.6.5 INTENSITY OF COMPETITIVE RIVALRY 88 5.7 REGULATORY ANALYSIS 88 5.7.1 NORTH AMERICA 88 5.7.1.1 US 88 TABLE 4 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES 89 FIGURE 28 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY 89 5.7.1.2 Canada 90 TABLE 5 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 90 FIGURE 29 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA 90 5.7.2 EUROPE 91 TABLE 6 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES 91 FIGURE 30 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 92 5.7.3 ASIA PACIFIC 93 5.7.3.1 Japan 93 TABLE 7 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 93 5.7.3.2 China 94 TABLE 8 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 94 5.7.3.3 India 94 FIGURE 31 INDIA: REGULATORY PROCESS FOR IVD DEVICES 95 5.8 PATENT ANALYSIS 95 5.8.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS 95 FIGURE 32 PATENT PUBLICATION TRENDS (2013–SEPTEMBER 2023) 96 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 96 FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2013–AUGUST 2023) 96 FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR MICROFLUIDICS PATENTS (JANUARY 2013–SEPTEMBER 2023) 97 5.9 TECHNOLOGY ANALYSIS 97 5.9.1 KEY TECHNOLOGIES 97 5.9.1.1 Biorecognition elements 98 5.9.1.2 Material science 98 5.9.1.3 Microfabrication 99 5.9.1.4 Direct-write 99 5.9.2 COMPLEMENTARY TECHNOLOGIES 99 5.9.2.1 MEMS 100 5.9.2.1.1 Micropumps 100 5.9.2.1.2 Microneedles 100 5.9.2.1.3 Microsensors/Transducers 101 5.9.3 ADJACENT TECHNOLOGIES 101 5.9.3.1 3D printing 101 5.9.3.2 Lab-on-fiber 102 5.9.4 KEY CONFERENCES & EVENTS 102 TABLE 9 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023–2024) 102 5.10 KEY STAKEHOLDERS & BUYING CRITERIA 103 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 103 FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET 103 TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET 103 5.10.2 BUYING CRITERIA 104 FIGURE 36 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET 104 TABLE 11 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET 104 5.11 PRICING ANALYSIS 105 5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 105 5.11.2 AVERAGE SELLING PRICE TREND, BY COMPONENT 106 5.12 END-USER PERSPECTIVE & UNMET NEEDS 106 5.13 AI INTEGRATION IN MICROFLUIDICS MARKET 107 5.13.1 ARTIFICIAL INTELLIGENCE AND MICROFLUIDICS (PROJECT LOCAI) 107 5.13.2 AI AND MICROFLUIDICS TO BARCODE INDIVIDUAL CELLS 107 5.13.3 ARTIFICIAL INTELLIGENCE-CONTROLLED MICROFLUIDIC DEVICES FOR FLUID AUTOMATION AND BUBBLE REMOVAL OF IMMUNOASSAYS 108 6 MICROFLUIDICS MARKET, BY PRODUCT 109 6.1 INTRODUCTION 110 TABLE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110 6.2 MICROFLUIDICS-BASED DEVICES 110 6.2.1 RISING ADOPTION ATTRIBUTED TO VARIOUS ADVANTAGES OF MICROFLUIDICS DEVICES 110 TABLE 13 MICROFLUIDICS-BASED DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111 6.3 MICROFLUIDIC COMPONENTS 112 TABLE 14 MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112 6.3.1 BY TYPE 113 TABLE 15 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113 6.3.1.1 Microfluidic chips 113 6.3.1.1.1 Chips to hold largest share of components market 113 TABLE 16 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS 114 TABLE 17 MICROFLUIDIC CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115 6.3.1.2 Flow & pressure sensors 116 6.3.1.2.1 Advantages in cytometry and POCT To drive adoption in labs and research institutes 116 TABLE 18 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS 116 TABLE 19 FLOW & PRESSURE SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117 6.3.1.3 Flow & pressure controllers 118 6.3.1.3.1 High accuracy and control to boost growth 118 TABLE 20 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS 118 TABLE 21 FLOW & PRESSURE CONTROLLERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119 6.3.1.4 Microfluidic valves 119 6.3.1.4.1 Importance of valves in microfluidics to ensure sustained demand 119 TABLE 22 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS 120 TABLE 23 MICROFLUIDIC VALVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123 6.3.1.5 Micropumps 123 6.3.1.5.1 Need for precise fluid control and device miniaturization to support demand 123 TABLE 24 MICROPUMPS OFFERED BY KEY PLAYERS 124 TABLE 25 MICROPUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125 6.3.1.6 Microneedles 125 6.3.1.6.1 Convenience, painlessness, and widespread availability of injectable drugs to boost adoption 125 TABLE 26 MICRONEEDLES OFFERED BY KEY PLAYERS 126 TABLE 27 MICRONEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126 6.3.1.7 Other components 127 TABLE 28 OTHER MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127 6.3.2 BY MATERIAL 128 TABLE 29 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 128 6.3.2.1 Silicon 128 6.3.2.1.1 Silicon to dominate materials market 128 TABLE 30 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129 6.3.2.2 Polymers 129 6.3.2.2.1 Higher performance than glass or silicon to drive adoption 129 TABLE 31 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130 6.3.2.3 Glass 130 6.3.2.3.1 Fragility of glass-based components to limit adoption 130 TABLE 32 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131 7 MICROFLUIDICS MARKET, BY APPLICATION 132 7.1 INTRODUCTION 133 TABLE 33 MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133 7.2 IVD 133 TABLE 34 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 134 TABLE 35 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135 7.2.1 CLINICAL DIAGNOSTICS 135 7.2.1.1 Rising viral outbreaks to drive market 135 TABLE 36 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 136 7.2.2 POCT 136 7.2.2.1 POCT to hold second-largest share in IVD segment 136 TABLE 37 MICROFLUIDICS MARKET FOR POCT, BY COUNTRY, 2021–2028 (USD MILLION) 137 7.2.3 VETERINARY DIAGNOSTICS 138 7.2.3.1 Growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine to support market growth 138 TABLE 38 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 138 7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING 139 TABLE 39 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 139 TABLE 40 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140 7.3.1 LAB ANALYTICS 140 TABLE 41 MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141 TABLE 42 MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141 7.3.1.1 Proteomic analysis 142 7.3.1.1.1 Increasing demand for rapid proteomic analysis in drug development to propel market 142 TABLE 43 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 143 7.3.1.2 Genomic analysis 143 7.3.1.2.1 Increasing focus on decoding genomes to boost adoption of microfluidics in genomics 143 TABLE 44 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 144 7.3.1.3 Cell-based assays 145 7.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development to support market growth 145 TABLE 45 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 145 7.3.1.4 Capillary electrophoresis 146 7.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies to drive market 146 TABLE 46 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 147 7.3.2 MICRODISPENSING 147 7.3.2.1 Low sample & reagent consumption and ease of use to propel adoption of microdispensing systems 147 TABLE 47 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY COUNTRY, 2021–2028 (USD MILLION) 148 7.3.3 MICROREACTIONS 148 7.3.3.1 Increasing need for optimizing research and production to boost usage of microreaction technology 148 TABLE 48 MICROFLUIDICS MARKET FOR MICROREACTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149 7.4 THERAPEUTICS 150 TABLE 49 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 150 TABLE 50 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 151 7.4.1 DRUG DELIVERY 151 7.4.1.1 Drug discovery to hold largest share 151 TABLE 51 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152 7.4.2 WEARABLE DEVICES 153 7.4.2.1 Increasing demand for microfluidics-integrated wearable devices to boost growth 153 TABLE 52 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 154 8 MICROFLUIDICS MARKET, BY END USER 155 8.1 INTRODUCTION 156 TABLE 53 MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 156 8.2 HOSPITALS & DIAGNOSTIC CENTERS 156 8.2.1 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE END-USER MARKET 156 TABLE 54 MICROFLUIDICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 157 8.3 ACADEMIC & RESEARCH INSTITUTES 158 8.3.1 GROWING USE OF MICROFLUIDICS IN R&D AND RISING FUNDING TO FAVOR MARKET 158 TABLE 55 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 159 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 159 8.4.1 GROWING FOCUS ON LAUNCHING QUALITY DRUGS TO DRIVE MARKET 159 FIGURE 37 FDA APPROVALS FOR PERSONALIZED MEDICINE (2018–2022) 160 TABLE 56 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 161 9 MICROFLUIDICS MARKET, BY REGION 162 9.1 INTRODUCTION 163 FIGURE 38 MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2022) 163 TABLE 57 MICROFLUIDICS MARKET, BY REGION, 2021–2028 (USD MILLION) 164 9.2 NORTH AMERICA 164 9.2.1 NORTH AMERICA: RECESSION IMPACT 165 FIGURE 39 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 165 TABLE 58 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166 TABLE 59 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166 TABLE 60 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166 TABLE 61 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167 TABLE 62 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167 TABLE 63 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167 TABLE 64 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 65 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 66 NORTH AMERICA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 168 TABLE 67 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 169 9.2.2 US 169 9.2.2.1 US to dominate North American microfluidics market 169 TABLE 68 US: KEY MACROINDICATORS 170 TABLE 69 US: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 170 TABLE 70 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170 TABLE 71 US: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171 TABLE 72 US: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 73 US: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 74 US: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172 TABLE 75 US: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172 TABLE 76 US: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 172 TABLE 77 US: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 173 9.2.3 CANADA 173 9.2.3.1 Strong infrastructure and availability of funding for biomedical research to support market growth 173 TABLE 78 CANADA: KEY MACROINDICATORS 174 TABLE 79 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174 TABLE 80 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175 TABLE 81 CANADA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175 TABLE 82 CANADA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 83 CANADA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 84 CANADA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 85 CANADA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177 TABLE 86 CANADA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 177 TABLE 87 CANADA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 177 9.3 EUROPE 178 9.3.1 EUROPE: RECESSION IMPACT 178 TABLE 88 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179 TABLE 89 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 179 TABLE 90 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180 TABLE 91 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180 TABLE 92 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181 TABLE 93 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181 TABLE 94 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181 TABLE 95 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182 TABLE 96 EUROPE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 182 TABLE 97 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 182 9.3.2 GERMANY 183 9.3.2.1 Germany to dominate European market 183 TABLE 98 GERMANY: KEY MACROINDICATORS 183 TABLE 99 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184 TABLE 100 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184 TABLE 101 GERMANY: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184 TABLE 102 GERMANY: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185 TABLE 103 GERMANY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185 TABLE 104 GERMANY: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185 TABLE 105 GERMANY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186 TABLE 106 GERMANY: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 186 TABLE 107 GERMANY: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 186 9.3.3 FRANCE 187 9.3.3.1 Strong government support for genomics and proteomics research to drive market 187 TABLE 108 FRANCE: KEY MACROINDICATORS 187 TABLE 109 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187 TABLE 110 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188 TABLE 111 FRANCE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188 TABLE 112 FRANCE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189 TABLE 113 FRANCE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189 TABLE 114 FRANCE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189 TABLE 115 FRANCE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190 TABLE 116 FRANCE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 190 TABLE 117 FRANCE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 190 9.3.4 UK 191 9.3.4.1 Increasing incidence of infectious diseases to drive demand for POCT and microfluidics 191 TABLE 118 UK: KEY MACROINDICATORS 191 TABLE 119 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 191 TABLE 120 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192 TABLE 121 UK: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192 TABLE 122 UK: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193 TABLE 123 UK: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193 TABLE 124 UK: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193 TABLE 125 UK: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 194 TABLE 126 UK: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 194 TABLE 127 UK: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 194 9.3.5 ITALY 195 9.3.5.1 Increasing demand for POCT to aid market growth 195 TABLE 128 ITALY: KEY MACROINDICATORS 195 TABLE 129 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195 TABLE 130 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196 TABLE 131 ITALY: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 196 TABLE 132 ITALY: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197 TABLE 133 ITALY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197 TABLE 134 ITALY: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197 TABLE 135 ITALY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198 TABLE 136 ITALY: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 198 TABLE 137 ITALY: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 198 9.3.6 SPAIN 199 9.3.6.1 Increasing incidence of infectious and chronic diseases to drive market 199 TABLE 138 SPAIN: KEY MACROINDICATORS 199 TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 200 TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 200 TABLE 141 SPAIN: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200 TABLE 142 SPAIN: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201 TABLE 143 SPAIN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201 TABLE 144 SPAIN: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201 TABLE 145 SPAIN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202 TABLE 146 SPAIN: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 202 TABLE 147 SPAIN: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 202 9.3.7 REST OF EUROPE 203 TABLE 148 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 203 TABLE 149 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 204 TABLE 150 REST OF EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204 TABLE 151 REST OF EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205 TABLE 152 REST OF EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205 TABLE 153 REST OF EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205 TABLE 154 REST OF EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206 TABLE 155 REST OF EUROPE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 206 TABLE 156 REST OF EUROPE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 206 9.4 ASIA PACIFIC 207 9.4.1 ASIA PACIFIC: RECESSION IMPACT 207 FIGURE 40 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 208 TABLE 157 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 209 TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 209 TABLE 159 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210 TABLE 160 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 210 TABLE 161 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211 TABLE 162 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211 TABLE 163 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211 TABLE 164 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 212 TABLE 165 ASIA PACIFIC: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 212 TABLE 166 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 212 9.4.2 CHINA 213 9.4.2.1 China to hold major share of APAC microfluidics market 213 TABLE 167 CHINA: KEY MACROINDICATORS 213 TABLE 168 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213 TABLE 169 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214 TABLE 170 CHINA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214 TABLE 171 CHINA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215 TABLE 172 CHINA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215 TABLE 173 CHINA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215 TABLE 174 CHINA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 216 TABLE 175 CHINA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 216 TABLE 176 CHINA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 216 9.4.3 JAPAN 217 9.4.3.1 Adoption of advanced lab instruments in research to drive market growth 217 TABLE 177 JAPAN: KEY MACROINDICATORS 217 TABLE 178 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 218 TABLE 179 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218 TABLE 180 JAPAN: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 218 TABLE 181 JAPAN: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219 TABLE 182 JAPAN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219 TABLE 183 JAPAN: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219 TABLE 184 JAPAN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 220 TABLE 185 JAPAN: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 220 TABLE 186 JAPAN: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 220 9.4.4 INDIA 221 9.4.4.1 Growing pharma R&D and government funding for biotech to boost market growth 221 TABLE 187 INDIA: KEY MACROINDICATORS 221 TABLE 188 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 222 TABLE 189 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222 TABLE 190 INDIA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 222 TABLE 191 INDIA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223 TABLE 192 INDIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223 TABLE 193 INDIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223 TABLE 194 INDIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 224 TABLE 195 INDIA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 224 TABLE 196 INDIA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 224 9.4.5 AUSTRALIA 225 9.4.5.1 Increasing prevalence of infectious diseases, especially influenza, to drive market 225 TABLE 197 AUSTRALIA: KEY MACROINDICATORS 225 TABLE 198 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225 TABLE 199 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226 TABLE 200 AUSTRALIA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 226 TABLE 201 AUSTRALIA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227 TABLE 202 AUSTRALIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227 TABLE 203 AUSTRALIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227 TABLE 204 AUSTRALIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 228 TABLE 205 AUSTRALIA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 228 TABLE 206 AUSTRALIA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 228 9.4.6 SOUTH KOREA 229 9.4.6.1 Increasing healthcare expenditure to support growth 229 TABLE 207 SOUTH KOREA: KEY MACROINDICATORS 229 TABLE 208 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 229 TABLE 209 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230 TABLE 210 SOUTH KOREA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230 TABLE 211 SOUTH KOREA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231 TABLE 212 SOUTH KOREA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231 TABLE 213 SOUTH KOREA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231 TABLE 214 SOUTH KOREA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 232 TABLE 215 SOUTH KOREA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 232 TABLE 216 SOUTH KOREA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 232 9.4.7 REST OF ASIA PACIFIC 233 TABLE 217 ROAPAC: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 233 TABLE 218 ROAPAC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233 TABLE 219 ROAPAC: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234 TABLE 220 ROAPAC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 234 TABLE 221 ROAPAC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 234 TABLE 222 ROAPAC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235 TABLE 223 ROAPAC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235 TABLE 224 ROAPAC: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 235 TABLE 225 ROAPAC: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 236
SummaryThe microfluidics market is valued at an estimated USD 22.3 billion in 2023 and is projected to reach USD 41.1 billion by 2028, at a CAGR of 13.0% during the forecast period. Microfluidics technologies minimize the overall cost of the drug development process by providing quick analysis, reduced reagent use, and reliable results of tests. Besides all of these factors, the demand for microfluidics technology is rising as a result of the expanding use and acceptance of point-of-care diagnostics tools like glucose monitors and pregnancy test kits. Table of Contents1 INTRODUCTION 411.1 STUDY OBJECTIVES 41 1.2 MARKET DEFINITION 42 1.2.1 PRODUCT DEFINITIONS 42 1.2.2 INCLUSIONS & EXCLUSIONS 43 1.3 MARKET SCOPE 44 1.3.1 MARKETS COVERED 44 1.3.2 YEARS CONSIDERED 45 1.4 CURRENCY 45 1.5 SCOPE-RELATED LIMITATIONS 46 1.6 STAKEHOLDERS 46 1.7 SUMMARY OF CHANGES 46 1.7.1 ADDITION OF RECESSION IMPACT 47 2 RESEARCH METHODOLOGY 48 2.1 RESEARCH DATA 48 FIGURE 1 RESEARCH DESIGN 48 2.1.1 SECONDARY DATA 49 2.1.1.1 Key data from secondary sources 50 2.1.2 PRIMARY DATA 50 FIGURE 2 PRIMARY SOURCES 51 2.1.2.1 Key data from primary sources 52 2.1.2.2 Key industry insights 53 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 53 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 54 2.2 MARKET SIZE ESTIMATION 54 FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 55 FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: DANAHER CORPORATION 55 FIGURE 7 REVENUE ANALYSIS OF TOP FOUR COMPANIES: MICROFLUIDICS-BASED DEVICES MARKET (2022) 56 FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MICROFLUIDICS MARKET (2023–2028) 58 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 59 FIGURE 10 TOP-DOWN APPROACH 59 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 61 FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 61 2.4 MARKET SHARE ANALYSIS 62 2.5 STUDY ASSUMPTIONS 62 2.6 LIMITATIONS 63 2.7 RISK ASSESSMENT 63 TABLE 1 RISK ASSESSMENT: MICROFLUIDICS MARKET 63 2.8 RECESSION IMPACT ANALYSIS 63 3 EXECUTIVE SUMMARY 64 FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 64 FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 65 FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 65 FIGURE 15 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023 VS. 2028 (USD MILLION) 66 FIGURE 16 MICROFLUIDICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 66 FIGURE 17 GEOGRAPHIC SNAPSHOT: MICROFLUIDICS MARKET 67 4 PREMIUM INSIGHTS 68 4.1 MICROFLUIDICS MARKET OVERVIEW 68 FIGURE 18 RISING DEMAND FOR POCT TO DRIVE GLOBAL MICROFLUIDICS MARKET 68 4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION & COUNTRY 69 FIGURE 19 IVD HELD LARGEST SHARE OF APAC MICROFLUIDICS MARKET IN 2022 69 4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70 FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 70 4.4 REGIONAL MIX: MICROFLUIDICS MARKET (2021–2028) 71 FIGURE 21 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET THROUGHOUT FORECAST PERIOD 71 4.5 MICROFLUIDICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 71 FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES TILL 2028 71 5 MARKET OVERVIEW 72 5.1 MARKET DYNAMICS 72 FIGURE 23 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 72 5.1.1 MARKET DRIVERS 73 5.1.1.1 Rising demand for point-of-care testing 73 FIGURE 24 GLOBAL CANCER INCIDENCE, 2020–2040 73 5.1.1.2 Rising technological advancements 74 TABLE 2 PRODUCT LAUNCHES BY MAJOR PLAYERS IN LAST THREE YEARS 74 5.1.1.3 Increasing focus on data precision and accuracy 74 5.1.1.4 Highly economical solution 75 5.1.1.5 Rapid testing and improved portability through microfluidic chip miniaturization 75 5.1.2 MARKET RESTRAINTS 76 5.1.2.1 Complex and time-consuming regulatory approval process 76 5.1.2.2 Incorporation of microfluidics into existing workflows 76 5.1.3 MARKET OPPORTUNITIES 77 5.1.3.1 Emergence of microfluidic-based 3D cell culture systems 77 5.1.3.2 Growth opportunities in Asia 77 5.1.3.3 Expanding applications of drug delivery technologies using microfluidics 78 5.1.3.4 Growing applications of microfluidics in life science & pharmaceutical industries 78 5.1.4 MARKET CHALLENGES 78 5.1.4.1 Standardization/commercialization of microfluidic devices 78 5.2 INDUSTRY TRENDS 79 5.2.1 SHIFTING TREND TOWARD E-HEALTH DIAGNOSTICS WITH INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES 79 5.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS 79 5.2.3 SHIFTING TREND TOWARDS ADOPTION OF POLYMERS 80 5.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC STARTUPS 80 TABLE 3 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET 80 5.3 VALUE CHAIN ANALYSIS 82 FIGURE 25 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS 83 5.3.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS 83 5.4 SUPPLY CHAIN ANALYSIS 84 FIGURE 26 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS 85 5.5 ECOSYSTEM MARKET MAP 85 FIGURE 27 MICROFLUIDICS MARKET: ECOSYSTEM MARKET MAP 86 5.6 PORTER’S FIVE FORCES ANALYSIS 86 5.6.1 THREAT OF NEW ENTRANTS 87 5.6.2 THREAT OF SUBSTITUTES 87 5.6.3 BARGAINING POWER OF SUPPLIERS 87 5.6.4 BARGAINING POWER OF BUYERS 88 5.6.5 INTENSITY OF COMPETITIVE RIVALRY 88 5.7 REGULATORY ANALYSIS 88 5.7.1 NORTH AMERICA 88 5.7.1.1 US 88 TABLE 4 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES 89 FIGURE 28 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY 89 5.7.1.2 Canada 90 TABLE 5 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 90 FIGURE 29 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA 90 5.7.2 EUROPE 91 TABLE 6 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES 91 FIGURE 30 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 92 5.7.3 ASIA PACIFIC 93 5.7.3.1 Japan 93 TABLE 7 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 93 5.7.3.2 China 94 TABLE 8 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 94 5.7.3.3 India 94 FIGURE 31 INDIA: REGULATORY PROCESS FOR IVD DEVICES 95 5.8 PATENT ANALYSIS 95 5.8.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS 95 FIGURE 32 PATENT PUBLICATION TRENDS (2013–SEPTEMBER 2023) 96 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 96 FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2013–AUGUST 2023) 96 FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR MICROFLUIDICS PATENTS (JANUARY 2013–SEPTEMBER 2023) 97 5.9 TECHNOLOGY ANALYSIS 97 5.9.1 KEY TECHNOLOGIES 97 5.9.1.1 Biorecognition elements 98 5.9.1.2 Material science 98 5.9.1.3 Microfabrication 99 5.9.1.4 Direct-write 99 5.9.2 COMPLEMENTARY TECHNOLOGIES 99 5.9.2.1 MEMS 100 5.9.2.1.1 Micropumps 100 5.9.2.1.2 Microneedles 100 5.9.2.1.3 Microsensors/Transducers 101 5.9.3 ADJACENT TECHNOLOGIES 101 5.9.3.1 3D printing 101 5.9.3.2 Lab-on-fiber 102 5.9.4 KEY CONFERENCES & EVENTS 102 TABLE 9 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023–2024) 102 5.10 KEY STAKEHOLDERS & BUYING CRITERIA 103 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 103 FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET 103 TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET 103 5.10.2 BUYING CRITERIA 104 FIGURE 36 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET 104 TABLE 11 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET 104 5.11 PRICING ANALYSIS 105 5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 105 5.11.2 AVERAGE SELLING PRICE TREND, BY COMPONENT 106 5.12 END-USER PERSPECTIVE & UNMET NEEDS 106 5.13 AI INTEGRATION IN MICROFLUIDICS MARKET 107 5.13.1 ARTIFICIAL INTELLIGENCE AND MICROFLUIDICS (PROJECT LOCAI) 107 5.13.2 AI AND MICROFLUIDICS TO BARCODE INDIVIDUAL CELLS 107 5.13.3 ARTIFICIAL INTELLIGENCE-CONTROLLED MICROFLUIDIC DEVICES FOR FLUID AUTOMATION AND BUBBLE REMOVAL OF IMMUNOASSAYS 108 6 MICROFLUIDICS MARKET, BY PRODUCT 109 6.1 INTRODUCTION 110 TABLE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110 6.2 MICROFLUIDICS-BASED DEVICES 110 6.2.1 RISING ADOPTION ATTRIBUTED TO VARIOUS ADVANTAGES OF MICROFLUIDICS DEVICES 110 TABLE 13 MICROFLUIDICS-BASED DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111 6.3 MICROFLUIDIC COMPONENTS 112 TABLE 14 MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112 6.3.1 BY TYPE 113 TABLE 15 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113 6.3.1.1 Microfluidic chips 113 6.3.1.1.1 Chips to hold largest share of components market 113 TABLE 16 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS 114 TABLE 17 MICROFLUIDIC CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115 6.3.1.2 Flow & pressure sensors 116 6.3.1.2.1 Advantages in cytometry and POCT To drive adoption in labs and research institutes 116 TABLE 18 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS 116 TABLE 19 FLOW & PRESSURE SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117 6.3.1.3 Flow & pressure controllers 118 6.3.1.3.1 High accuracy and control to boost growth 118 TABLE 20 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS 118 TABLE 21 FLOW & PRESSURE CONTROLLERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119 6.3.1.4 Microfluidic valves 119 6.3.1.4.1 Importance of valves in microfluidics to ensure sustained demand 119 TABLE 22 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS 120 TABLE 23 MICROFLUIDIC VALVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123 6.3.1.5 Micropumps 123 6.3.1.5.1 Need for precise fluid control and device miniaturization to support demand 123 TABLE 24 MICROPUMPS OFFERED BY KEY PLAYERS 124 TABLE 25 MICROPUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125 6.3.1.6 Microneedles 125 6.3.1.6.1 Convenience, painlessness, and widespread availability of injectable drugs to boost adoption 125 TABLE 26 MICRONEEDLES OFFERED BY KEY PLAYERS 126 TABLE 27 MICRONEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126 6.3.1.7 Other components 127 TABLE 28 OTHER MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127 6.3.2 BY MATERIAL 128 TABLE 29 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 128 6.3.2.1 Silicon 128 6.3.2.1.1 Silicon to dominate materials market 128 TABLE 30 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129 6.3.2.2 Polymers 129 6.3.2.2.1 Higher performance than glass or silicon to drive adoption 129 TABLE 31 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130 6.3.2.3 Glass 130 6.3.2.3.1 Fragility of glass-based components to limit adoption 130 TABLE 32 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131 7 MICROFLUIDICS MARKET, BY APPLICATION 132 7.1 INTRODUCTION 133 TABLE 33 MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133 7.2 IVD 133 TABLE 34 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 134 TABLE 35 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135 7.2.1 CLINICAL DIAGNOSTICS 135 7.2.1.1 Rising viral outbreaks to drive market 135 TABLE 36 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 136 7.2.2 POCT 136 7.2.2.1 POCT to hold second-largest share in IVD segment 136 TABLE 37 MICROFLUIDICS MARKET FOR POCT, BY COUNTRY, 2021–2028 (USD MILLION) 137 7.2.3 VETERINARY DIAGNOSTICS 138 7.2.3.1 Growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine to support market growth 138 TABLE 38 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 138 7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING 139 TABLE 39 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 139 TABLE 40 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140 7.3.1 LAB ANALYTICS 140 TABLE 41 MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141 TABLE 42 MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141 7.3.1.1 Proteomic analysis 142 7.3.1.1.1 Increasing demand for rapid proteomic analysis in drug development to propel market 142 TABLE 43 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 143 7.3.1.2 Genomic analysis 143 7.3.1.2.1 Increasing focus on decoding genomes to boost adoption of microfluidics in genomics 143 TABLE 44 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 144 7.3.1.3 Cell-based assays 145 7.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development to support market growth 145 TABLE 45 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 145 7.3.1.4 Capillary electrophoresis 146 7.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies to drive market 146 TABLE 46 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 147 7.3.2 MICRODISPENSING 147 7.3.2.1 Low sample & reagent consumption and ease of use to propel adoption of microdispensing systems 147 TABLE 47 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY COUNTRY, 2021–2028 (USD MILLION) 148 7.3.3 MICROREACTIONS 148 7.3.3.1 Increasing need for optimizing research and production to boost usage of microreaction technology 148 TABLE 48 MICROFLUIDICS MARKET FOR MICROREACTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149 7.4 THERAPEUTICS 150 TABLE 49 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 150 TABLE 50 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 151 7.4.1 DRUG DELIVERY 151 7.4.1.1 Drug discovery to hold largest share 151 TABLE 51 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152 7.4.2 WEARABLE DEVICES 153 7.4.2.1 Increasing demand for microfluidics-integrated wearable devices to boost growth 153 TABLE 52 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 154 8 MICROFLUIDICS MARKET, BY END USER 155 8.1 INTRODUCTION 156 TABLE 53 MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 156 8.2 HOSPITALS & DIAGNOSTIC CENTERS 156 8.2.1 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE END-USER MARKET 156 TABLE 54 MICROFLUIDICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 157 8.3 ACADEMIC & RESEARCH INSTITUTES 158 8.3.1 GROWING USE OF MICROFLUIDICS IN R&D AND RISING FUNDING TO FAVOR MARKET 158 TABLE 55 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 159 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 159 8.4.1 GROWING FOCUS ON LAUNCHING QUALITY DRUGS TO DRIVE MARKET 159 FIGURE 37 FDA APPROVALS FOR PERSONALIZED MEDICINE (2018–2022) 160 TABLE 56 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 161 9 MICROFLUIDICS MARKET, BY REGION 162 9.1 INTRODUCTION 163 FIGURE 38 MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2022) 163 TABLE 57 MICROFLUIDICS MARKET, BY REGION, 2021–2028 (USD MILLION) 164 9.2 NORTH AMERICA 164 9.2.1 NORTH AMERICA: RECESSION IMPACT 165 FIGURE 39 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 165 TABLE 58 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166 TABLE 59 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166 TABLE 60 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166 TABLE 61 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167 TABLE 62 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167 TABLE 63 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167 TABLE 64 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 65 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168 TABLE 66 NORTH AMERICA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 168 TABLE 67 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 169 9.2.2 US 169 9.2.2.1 US to dominate North American microfluidics market 169 TABLE 68 US: KEY MACROINDICATORS 170 TABLE 69 US: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 170 TABLE 70 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170 TABLE 71 US: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171 TABLE 72 US: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 73 US: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 171 TABLE 74 US: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172 TABLE 75 US: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172 TABLE 76 US: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 172 TABLE 77 US: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 173 9.2.3 CANADA 173 9.2.3.1 Strong infrastructure and availability of funding for biomedical research to support market growth 173 TABLE 78 CANADA: KEY MACROINDICATORS 174 TABLE 79 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174 TABLE 80 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175 TABLE 81 CANADA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175 TABLE 82 CANADA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 83 CANADA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 84 CANADA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176 TABLE 85 CANADA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177 TABLE 86 CANADA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 177 TABLE 87 CANADA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 177 9.3 EUROPE 178 9.3.1 EUROPE: RECESSION IMPACT 178 TABLE 88 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179 TABLE 89 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 179 TABLE 90 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180 TABLE 91 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180 TABLE 92 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181 TABLE 93 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181 TABLE 94 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 181 TABLE 95 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 182 TABLE 96 EUROPE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 182 TABLE 97 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 182 9.3.2 GERMANY 183 9.3.2.1 Germany to dominate European market 183 TABLE 98 GERMANY: KEY MACROINDICATORS 183 TABLE 99 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184 TABLE 100 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184 TABLE 101 GERMANY: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184 TABLE 102 GERMANY: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185 TABLE 103 GERMANY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185 TABLE 104 GERMANY: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185 TABLE 105 GERMANY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 186 TABLE 106 GERMANY: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 186 TABLE 107 GERMANY: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 186 9.3.3 FRANCE 187 9.3.3.1 Strong government support for genomics and proteomics research to drive market 187 TABLE 108 FRANCE: KEY MACROINDICATORS 187 TABLE 109 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187 TABLE 110 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188 TABLE 111 FRANCE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188 TABLE 112 FRANCE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189 TABLE 113 FRANCE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189 TABLE 114 FRANCE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 189 TABLE 115 FRANCE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 190 TABLE 116 FRANCE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 190 TABLE 117 FRANCE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 190 9.3.4 UK 191 9.3.4.1 Increasing incidence of infectious diseases to drive demand for POCT and microfluidics 191 TABLE 118 UK: KEY MACROINDICATORS 191 TABLE 119 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 191 TABLE 120 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192 TABLE 121 UK: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192 TABLE 122 UK: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193 TABLE 123 UK: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193 TABLE 124 UK: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193 TABLE 125 UK: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 194 TABLE 126 UK: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 194 TABLE 127 UK: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 194 9.3.5 ITALY 195 9.3.5.1 Increasing demand for POCT to aid market growth 195 TABLE 128 ITALY: KEY MACROINDICATORS 195 TABLE 129 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195 TABLE 130 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196 TABLE 131 ITALY: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 196 TABLE 132 ITALY: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197 TABLE 133 ITALY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197 TABLE 134 ITALY: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197 TABLE 135 ITALY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198 TABLE 136 ITALY: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 198 TABLE 137 ITALY: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 198 9.3.6 SPAIN 199 9.3.6.1 Increasing incidence of infectious and chronic diseases to drive market 199 TABLE 138 SPAIN: KEY MACROINDICATORS 199 TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 200 TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 200 TABLE 141 SPAIN: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200 TABLE 142 SPAIN: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201 TABLE 143 SPAIN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201 TABLE 144 SPAIN: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201 TABLE 145 SPAIN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 202 TABLE 146 SPAIN: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 202 TABLE 147 SPAIN: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 202 9.3.7 REST OF EUROPE 203 TABLE 148 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 203 TABLE 149 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 204 TABLE 150 REST OF EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204 TABLE 151 REST OF EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205 TABLE 152 REST OF EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205 TABLE 153 REST OF EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205 TABLE 154 REST OF EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 206 TABLE 155 REST OF EUROPE: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 206 TABLE 156 REST OF EUROPE: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 206 9.4 ASIA PACIFIC 207 9.4.1 ASIA PACIFIC: RECESSION IMPACT 207 FIGURE 40 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 208 TABLE 157 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 209 TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 209 TABLE 159 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210 TABLE 160 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 210 TABLE 161 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211 TABLE 162 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211 TABLE 163 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 211 TABLE 164 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 212 TABLE 165 ASIA PACIFIC: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 212 TABLE 166 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 212 9.4.2 CHINA 213 9.4.2.1 China to hold major share of APAC microfluidics market 213 TABLE 167 CHINA: KEY MACROINDICATORS 213 TABLE 168 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213 TABLE 169 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214 TABLE 170 CHINA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214 TABLE 171 CHINA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215 TABLE 172 CHINA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215 TABLE 173 CHINA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 215 TABLE 174 CHINA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 216 TABLE 175 CHINA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 216 TABLE 176 CHINA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 216 9.4.3 JAPAN 217 9.4.3.1 Adoption of advanced lab instruments in research to drive market growth 217 TABLE 177 JAPAN: KEY MACROINDICATORS 217 TABLE 178 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 218 TABLE 179 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218 TABLE 180 JAPAN: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 218 TABLE 181 JAPAN: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219 TABLE 182 JAPAN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219 TABLE 183 JAPAN: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 219 TABLE 184 JAPAN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 220 TABLE 185 JAPAN: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 220 TABLE 186 JAPAN: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 220 9.4.4 INDIA 221 9.4.4.1 Growing pharma R&D and government funding for biotech to boost market growth 221 TABLE 187 INDIA: KEY MACROINDICATORS 221 TABLE 188 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 222 TABLE 189 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222 TABLE 190 INDIA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 222 TABLE 191 INDIA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223 TABLE 192 INDIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223 TABLE 193 INDIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223 TABLE 194 INDIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 224 TABLE 195 INDIA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 224 TABLE 196 INDIA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 224 9.4.5 AUSTRALIA 225 9.4.5.1 Increasing prevalence of infectious diseases, especially influenza, to drive market 225 TABLE 197 AUSTRALIA: KEY MACROINDICATORS 225 TABLE 198 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225 TABLE 199 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226 TABLE 200 AUSTRALIA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 226 TABLE 201 AUSTRALIA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227 TABLE 202 AUSTRALIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227 TABLE 203 AUSTRALIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227 TABLE 204 AUSTRALIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 228 TABLE 205 AUSTRALIA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 228 TABLE 206 AUSTRALIA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 228 9.4.6 SOUTH KOREA 229 9.4.6.1 Increasing healthcare expenditure to support growth 229 TABLE 207 SOUTH KOREA: KEY MACROINDICATORS 229 TABLE 208 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 229 TABLE 209 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230 TABLE 210 SOUTH KOREA: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230 TABLE 211 SOUTH KOREA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231 TABLE 212 SOUTH KOREA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231 TABLE 213 SOUTH KOREA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 231 TABLE 214 SOUTH KOREA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 232 TABLE 215 SOUTH KOREA: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 232 TABLE 216 SOUTH KOREA: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 232 9.4.7 REST OF ASIA PACIFIC 233 TABLE 217 ROAPAC: MICROFLUIDICS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 233 TABLE 218 ROAPAC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233 TABLE 219 ROAPAC: MICROFLUIDICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234 TABLE 220 ROAPAC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 234 TABLE 221 ROAPAC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 234 TABLE 222 ROAPAC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235 TABLE 223 ROAPAC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235 TABLE 224 ROAPAC: MICROFLUIDICS MARKET, BY END USER, 2021–2028 (USD MILLION) 235 TABLE 225 ROAPAC: MICROFLUIDICS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 236
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(産業機械)の最新刊レポート
MarketsandMarkets社のAnalytical and Scientific Instrumentation分野での最新刊レポート
本レポートと同じKEY WORD(chip)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |